Page last updated: 2024-08-21

hematoxylin and Airflow Obstruction, Chronic

hematoxylin has been researched along with Airflow Obstruction, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, C; Fu, P; Kumar, N; Lu, C; Madabhushi, A; Verma, R; Willis, J1
Chang, C; Li, D; Sun, Y; Zhang, L1
Cong, JP; Mi, LY; Yu, WC1

Other Studies

3 other study(ies) available for hematoxylin and Airflow Obstruction, Chronic

ArticleYear
Computer-extracted features of nuclear morphology in hematoxylin and eosin images distinguish stage II and IV colon tumors.
    The Journal of pathology, 2022, Volume: 257, Issue:1

    Topics: Colonic Neoplasms; Computers; Eosine Yellowish-(YS); Hematoxylin; Humans; Pulmonary Disease, Chronic Obstructive

2022
Myostatin/HIF2α-Mediated Ferroptosis is Involved in Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease.
    International journal of chronic obstructive pulmonary disease, 2022, Volume: 17

    Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Eosine Yellowish-(YS); Ferroptosis; Hematoxylin; Iron; Lipid Peroxides; Mice; Muscle, Skeletal; Myostatin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Reactive Oxygen Species; RNA, Messenger

2022
Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remo
    Revista da Associacao Medica Brasileira (1992), 2018, Volume: 64, Issue:4

    Topics: Case-Control Studies; Forced Expiratory Volume; Hematoxylin; Humans; Immunohistochemistry; Lung; Male; Matrix Metalloproteinase 9; Middle Aged; Myocytes, Smooth Muscle; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Reference Values; Tissue Inhibitor of Metalloproteinase-1; Toll-Like Receptor 4; Vascular Remodeling; Vital Capacity

2018